Quick Answer
Tango Therapeutics, Inc. reported Total Assets of $398.69 million for fiscal year 2025.
Tango Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $398.69M | +26.0% |
| 2024 | $316.49M | -21.4% |
| 2023 | $402.57M | -7.8% |
| 2022 | $436.47M | -12.7% |
| 2021 | $500.15M | +141.3% |
| 2020 | $207.25M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $210.14M | -40.4% | -11.7% |
| June 30, 2025 | $237.89M | -37.6% | -13.3% |
| March 31, 2025 | $274.31M | -32.5% | -13.3% |
| December 31, 2024 | $316.49M | -21.4% | -10.2% |
| September 30, 2024 | $352.42M | -17.7% | -7.6% |
| June 30, 2024 | $381.45M | +0.6% | -6.1% |
| March 31, 2024 | $406.22M | +0.6% | +0.9% |
| December 31, 2023 | $402.57M | -7.8% | -6.0% |
- Tango Therapeutics, Inc. showed an increase of +26.0% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Tango Therapeutics, Inc.’s total assets has grown by 92.4% (from $207.25 million to $398.69 million).
- The most recent figure is from Tango Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: